Biocon Q4 consolidated net surges 78%
During the quarter, Biocon reported exceptional gain of Rs 105.06 crore on account of share sale in its research services subsidiary Syngene.
Apr 30, 2015, 11:31 AM IST
During the quarter, Biocon reported exceptional gain of Rs 105.06 crore on account of share sale in its research services subsidiary Syngene.
Apr 30, 2015, 11:31 AM IST